We're thrilled to announce that Pluto has been selected as one of 20 companies in the 2024 cohort of the BioTools Innovator Accelerator, the first accelerator dedicated to supporting life science tools.
From Kathryn Zavala, Managing Director: "BioTools Innovator’s mission is to nurture the life science entrepreneurs whose technologies enable more efficient drug discovery and development processes.”
At Pluto, we're driven by the mission to accelerate drug discovery by making multi-omics data analysis accessible to every scientist. Our selection for this ground-breaking cohort is a testament to the impact our platform is already making for scientists in biopharma, and represents an exciting opportunity for Pluto to expand with the expertise of distinguished thought leaders in the biotools industry.
We congratulate all of the companies selected!
Visit the Business Wire article